Hostname: page-component-cb9f654ff-d5ftd Total loading time: 0 Render date: 2025-09-05T17:59:21.687Z Has data issue: false hasContentIssue false
  • English
  • Français

The Efficacy and Safety Profile of a New Antipsychotic, Ziprasidone

Published online by Cambridge University Press:  16 April 2020

R. O’Connor ,
E. Harrigan ,
J. Heym ,
G. Ko  and
L. Chandler
R. O’Connor
Affiliation:
Pfizer Central Research. Sandwich. Kent. CTJ3 9NJ. UK
E. Harrigan
Affiliation:
Pfizer Central Research, Groton. CT06340. USA
J. Heym
Affiliation:
Pfizer Central Research, Groton. CT06340. USA
G. Ko
Affiliation:
international Pharmaceuticals Group. PfizerInc. New York. NY10017. USA
L. Chandler
Affiliation:
Pfizer Central Research, Groton. CT06340. USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Submit a response

Comments

No Comments have been published for this article.